Evidence map›Paper›PMID 38543096›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

Effect of Botulinum Toxin Injections in the Treatment of Spasticity of Different Etiologies: An Umbrella Review.

Iris Otero-Luis, Arturo Martinez-Rodrigo, Iván Cavero-Redondo, Nerea Moreno-Herráiz, Irene Martínez-García, Alicia Saz-Lara

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Iris Otero-LuisHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.
Arturo Martinez-RodrigoDepartamento de Sistemas Informáticos (DSI), Facultad de Comunicación de Cuenca, University of Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-2343-3186
Iván Cavero-RedondoFacultad de Ciencias de la Salud, Universidad Autonoma de Chile, Talca 3460000, Chile.
Nerea Moreno-HerráizHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.
Irene Martínez-GarcíaHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0001-7835-6953
Alicia Saz-LaraHealth and Social Research Center, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-0669-8625
University of Castilla-La Mancha · ESUniversidad Autónoma de Chile · CL

Funding

ERDF funds and partially supported by Castilla-La Mancha Regional Government/FEDER, UE SBPLY/21/180501/000186.Grant from the science, innovation and universities FPU21/06866Junta de Comunidades de Castilla-La Mancha 2023-PREJCCM-000062
6 · The paper itself

Abstract

backgroundSpasticity is a very common neurological sequelae that significantly impacts the quality of life of patients, affecting more than 12 million people worldwide. Botulinum toxin is considered a reversible treatment for spasticity, but due to the large amount of available evidence, synthesis seems necessary. Therefore, we conducted an overview of existing systematic reviews and meta-analyses to evaluate the effect of botulinum toxin injections in the treatment of spasticity of different etiologies.

methodsA systematic search of different databases, including Pubmed, Scopus, the Cochrane Library, and Web of Science, was performed from inception to February 2024. Standardized mean differences (SMDs) and their respective 95% confidence intervals (CIs) were calculated to assess the effect of botulinum toxin compared to that of the control treatment using the Modified Ashworth Scale (MAS). All the statistical analyses were performed using STATA 15 software.

results28 studies were included in the umbrella review. The effect of botulinum toxin injections on spasticity, as measured by the MAS, was significantly lower in all but three studies, although these studies also supported the intervention. The SMDs reported by the meta-analyses ranged from -0.98 to -0.01.

conclusionBotulinum toxin injections were effective at treating spasticity of different etiologies, as indicated by the measurements on the MAS. This implies an improvement in muscle tone and, consequently, in the patient's mobility and quality of life.

Indexed as

botulinum toxin injectionsetiologiesgeneral populationspasticityumbrella review

Identifiers

PMID38543096
PMCPMC10976034
OpenAlexW4392239897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.